To lessen the symptoms of attention deficit disorder and enhance the quality of life for children with or without hyperactivity, a diagnosis and treatment plan is necessary. For children older than six, atomoxetine is the first non-stimulant drug available. It is only one component of treatment; other children may also benefit from more natural remedies, such as Omega 3. Thus, the following is the issue: Is atomoxetine a better dietary supplement than those based on Omega 3? Is it possible for atomoxetine to effectively reduce symptoms of attention deficit disorder, whether or not hyperactivity is present? Is Omega 3 a good enough substitute for methylphenidate in youngsters with hyperactivity? In order to address this, a prospective observational study was conducted at the psychiatry department of Tlemcen University Hospital in Algeria for duration of twelve months. The study had a comparative aim and used the Conners scale for parents. The sample of sixty children with ADHD was divided int otwo groups. The first before and after taking atomoxetine, and the second before and after using Omega 3, depending on the parents' preference. The study's finding suggests that while Omega 3 had no discernible impact, atomoxetine considerably reduced the disorder's primary symptoms of hyperactivity and inattention.

ADHD, inattention, hyperactivity, atomoxetine, Omega-3.